等待開盤 05-20 09:30:00 美东时间
+0.070
+0.36%
William Blair gives Kailera Therapeutics ($KLRA) an Outperform rating. Learn why analysts see a competitive edge in their GLP-1 assets.
05-14 02:43
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
JP Morgan analyst Hardik Parikh initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Overweight rating and announces Price Target of $30.
05-12 22:29
Kailera Therapeutics shares are trading higher amid post-IPO volatility.
04-20 22:56
伊朗开放霍尔木兹海峡,纳指涨超1.5%录得13连涨!追平1992年以来最长连涨纪录;大型科技股悉数走强,特斯拉涨超3%,苹果涨超2%;稀土概念股CRML大涨超35%>>
04-18 09:07
Kailera Therapeutics Inc.通过扩大首次公开发行(IPO)规模,成功募资6.25亿美元,创下2021年以来美国生物科技领域规模最大的IPO纪录。
04-17 11:33
Kailera Therapeutics于周一公布其首次公开募股(IPO)条款。
04-14 15:19
UPDATE 1-Kailera, Alamar launch US IPOs as biotech listings gather momentum Changes media packaging code to USA-IPO/BIOTECH, adds details on Kailera and Alamar IPOs throughout April 13 (Reuters) - Alamar Biosciences and Kailera Therapeutics kicked off roadshows for their U.S. initial public offering
04-13 19:58